The new era in clinical development
Join the growing number of biopharma teams that trust AIRA to move faster, avoid costly mistakes, and make defensible study design decisions.
Supported by
AIRA is a unified AI platform for study design and protocol development
At its core, AIRA is the only AI platform where your team collaborates with built-in expert-level clinical, regulatory, and medical writing AI thought partners that pay attention to your continuously evolving study context and develop it with you.
40% faster submission cycle
Save $150K+ to millions per study
Prevent up to 50% of amendments
Collaborate without chaos
Make confident, defensible decisions
Designed for regulated environments.
Security and compliance are embedded in the architecture - not added later. They define how we build our technical core, design our processes, and grow our organization.
Platform Capabilities
INTELLIGENCE
Provides clinical trial intelligence grounded in traceable evidence and expert reasoning
- Analyzes any question in full study context
- Applies built-in expert-grade clinical and regulatory reasoning
- Grounds answers in guidelines, precedents, and curated data, with clear references and an explained chain of thought
- Proactively adds insights and considerations to the discussion
- Recommends concrete next steps
Why it matters: Save hundreds of hours of research. Transform scattered information into actionable, study-specific insights. Make evidence-backed decisions you can confidently defend to regulators.
AUTHORING
Develops compliant study document drafts and implements changes
- Generates protocol drafts
- Suggests improvements and next steps as your study evolves
- When you instruct AIRA to make changes, it asks clarifying questions, identifies, and explains the downstream implications
- Implements changes across affected sections with medical writing expertise and with full traceability
Why it matters: Save weeks in protocol development. Maintain consistency across documents. Prevent avoidable amendments. Shift your team’s time from writing to strategic decision-making.
INSIGHTS AND REVIEW
Provides evidence-backed recommendations and reviews your documents with actionable guidance
- Runs continuous regulatory and feasibility checks based on expert best practices
- Flags regulatory risks, gaps, and optimization opportunities
- Recommends clear resolutions
- Allows you to run your organizational review playbooks
Why it matters: Catch regulatory and feasibility issues early to avoid amendments and submission delays. Strengthen strategic and regulatory alignment across your study design. Move from an external expert-first to an evidence-first study design.
CONTEXT AWARENESS
Connects and synthesizes evolving study information to suggest next steps, convert information into action, and prevent misalignment
- Tracks all documents, discussions, and study updates
- Connects information across drafts, comments, and research to help you formulate decisions
- Flags inconsistencies and misalignment
- Converts uploaded meeting notes into actionable next steps
Why it matters: Save days by turning static information into immediate next steps. Reduce back-and-forth and internal rework. Eliminate scattered information and preserve decision rationale.
“Working with AIRA feels like having an extra team of experts at the table with us for every decision and action”
VP of Clinical Development, Biotech
Built for every clinical team working on bringing treatments to patients faster and safer.
What our clients say
I started preparing for our meetings in AIRA by reviewing its insights, asking questions from it in advance so we start the meeting by discussing AIRA’s suggestions
Scientific Strategy Lead
Biotech
We use AIRA so we can prepare the first draft of the protocol and discuss our clinical strategy internally and only engage CROs later
CEO
Biotech
So many times, we don’t know what we don’t know, so I will personally make sure that everyone on the team reviews AIRA insights relevant to them
Senior Regulatory & Development Expert
Biotech
AIRA’s insights are really valuable, and the drafting with our template saves a lot of time. Also, I could use AIRA to generate a draft of the consent form for the study in minutes
Principal Investigator
Cancer Center
I started preparing for our meetings in AIRA by reviewing its insights, asking questions from it in advance so we start the meeting by discussing AIRA’s suggestions
Scientific Strategy Lead
Biotech
We use AIRA so we can prepare the first draft of the protocol and discuss our clinical strategy internally and only engage CROs later
CEO
Biotech
So many times, we don’t know what we don’t know, so I will personally make sure that everyone on the team reviews AIRA insights relevant to them
Senior Regulatory & Development Expert
Biotech
AIRA’s insights are really valuable, and the drafting with our template saves a lot of time. Also, I could use AIRA to generate a draft of the consent form for the study in minutes
Principal Investigator
Cancer Center
Join the growing community of biopharma teams using AIRA to move faster, reduce costs, and bring therapies to patients sooner.
Get early access, product updates, and clinical development insights delivered to your inbox.
Subscribe to our newsletter
40%
Faster submission cycle
$150K to millions
Saved per study
From 4-6 weeks
Faster protocol development
50%
Less amendments